Global Drug Discovery Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Drug Discovery Services Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.
Drug Discovery Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Drug Discovery Services market is projected to reach US$ 34250 million in 2033, increasing from US$ 17840 million in 2022, with the CAGR of 11.1% during the period of 2023 to 2033. Demand from Pharmaceutical Companies and Other are the major drivers for the industry.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Discovery Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Pharmaceutical Companies
Other
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug Discovery Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug Discovery Services introduction, etc. Drug Discovery Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug Discovery Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Drug Discovery Services report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Drug Discovery Services market is projected to reach US$ 34250 million in 2033, increasing from US$ 17840 million in 2022, with the CAGR of 11.1% during the period of 2023 to 2033. Demand from Pharmaceutical Companies and Other are the major drivers for the industry.
The Drug Discovery Services market refers to the range of services provided by contract research organizations (CROs) and other service providers to support the drug discovery and development process. This market includes services such as target identification, lead optimization, preclinical testing, and clinical trial support. The Drug Discovery Services market has been experiencing significant growth due to factors such as the increasing complexity of drug development, rising outsourcing of research activities, and the need for specialized expertise. Key players in the market include CROs, pharmaceutical companies, and biotechnology firms. Geographically, the market is global, with regions witnessing a growing demand for outsourced drug discovery services.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug Discovery Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
IQVIA
Charles River Laboratories
Aptuit
Evotec
GenScript
PPD
WuXi AppTec
AMRI
Segment by Type
Chemical Services
Biological Services
Lead Optimization
Lead Identification and Screening
Segment by Application
Pharmaceutical Companies
Other
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug Discovery Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug Discovery Services introduction, etc. Drug Discovery Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug Discovery Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.